Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9323 |
High Similarity |
NPD1240 |
Approved |
0.9191 |
High Similarity |
NPD1510 |
Phase 2 |
0.9185 |
High Similarity |
NPD1607 |
Approved |
0.9014 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.9014 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8993 |
High Similarity |
NPD1549 |
Phase 2 |
0.8921 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8921 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8836 |
High Similarity |
NPD4380 |
Phase 2 |
0.8776 |
High Similarity |
NPD7411 |
Suspended |
0.8714 |
High Similarity |
NPD2796 |
Approved |
0.8658 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8633 |
High Similarity |
NPD6651 |
Approved |
0.8609 |
High Similarity |
NPD7075 |
Discontinued |
0.86 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8552 |
High Similarity |
NPD6799 |
Approved |
0.8533 |
High Similarity |
NPD7819 |
Suspended |
0.8533 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8467 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8451 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8451 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8403 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8344 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8333 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8301 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8301 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.828 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8276 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8255 |
Intermediate Similarity |
NPD920 |
Approved |
0.8247 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8243 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8243 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8243 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8231 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.8219 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.8214 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8207 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8176 |
Intermediate Similarity |
NPD1511 |
Approved |
0.817 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8121 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.8095 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8089 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8067 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8038 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8027 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8025 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.8012 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.8012 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7975 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7972 |
Intermediate Similarity |
NPD943 |
Approved |
0.7937 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7937 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7937 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7911 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7898 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7895 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7891 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7885 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7857 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7848 |
Intermediate Similarity |
NPD919 |
Approved |
0.784 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7832 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7818 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7817 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7801 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7785 |
Intermediate Similarity |
NPD2654 |
Approved |
0.777 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7763 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7755 |
Intermediate Similarity |
NPD3748 |
Approved |
0.775 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7744 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7733 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7722 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7708 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7698 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7683 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7682 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7664 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7647 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7643 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7636 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7593 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7593 |
Intermediate Similarity |
NPD5710 |
Approved |
0.759 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7576 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7569 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7564 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7564 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7548 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7547 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7545 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7536 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7533 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7533 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.753 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7517 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7483 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7482 |
Intermediate Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.7467 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7467 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7467 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7467 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7467 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7467 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7466 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7447 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7447 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7439 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7432 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7432 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7432 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7396 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7386 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7386 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7386 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7379 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7371 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7371 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7361 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7361 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7358 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.733 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.733 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7324 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7315 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7299 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7292 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7285 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7285 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7279 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7278 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7257 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.725 |
Intermediate Similarity |
NPD5889 |
Approved |
0.725 |
Intermediate Similarity |
NPD5890 |
Approved |
0.7235 |
Intermediate Similarity |
NPD6104 |
Discontinued |
0.723 |
Intermediate Similarity |
NPD3764 |
Approved |
0.72 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7197 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7192 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7172 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7167 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7162 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.716 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7153 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7152 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7134 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7125 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7123 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7123 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7117 |
Intermediate Similarity |
NPD2296 |
Approved |
0.7117 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7115 |
Intermediate Similarity |
NPD3295 |
Clinical (unspecified phase) |
0.7114 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7114 |
Intermediate Similarity |
NPD411 |
Approved |
0.7114 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7113 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7103 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7101 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD4661 |
Approved |
0.7089 |
Intermediate Similarity |
NPD4662 |
Approved |
0.7086 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7081 |
Intermediate Similarity |
NPD6585 |
Discontinued |
0.7078 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7066 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7059 |
Intermediate Similarity |
NPD74 |
Approved |
0.7059 |
Intermediate Similarity |
NPD9266 |
Approved |
0.7055 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7055 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7055 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7045 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7045 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7042 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.7029 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7027 |
Intermediate Similarity |
NPD7584 |
Approved |
0.702 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.702 |
Intermediate Similarity |
NPD1613 |
Approved |
0.702 |
Intermediate Similarity |
NPD3142 |
Approved |
0.702 |
Intermediate Similarity |
NPD3140 |
Approved |
0.702 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7014 |
Intermediate Similarity |
NPD3847 |
Discontinued |
0.7013 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7013 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7006 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7006 |
Intermediate Similarity |
NPD2354 |
Approved |
0.6994 |
Remote Similarity |
NPD6280 |
Approved |
0.6994 |
Remote Similarity |
NPD37 |
Approved |
0.6994 |
Remote Similarity |
NPD6279 |
Approved |
0.6992 |
Remote Similarity |
NPD940 |
Approved |
0.6992 |
Remote Similarity |
NPD846 |
Approved |
0.6986 |
Remote Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.6985 |
Remote Similarity |
NPD9264 |
Approved |
0.6985 |
Remote Similarity |
NPD9265 |
Clinical (unspecified phase) |
0.6985 |
Remote Similarity |
NPD9267 |
Approved |
0.6985
|
Remote Similarity |
NPD9263 |
Approved |